Ventilator-Associated Pneumonia: Diagnosis, Prevention, Treatment (State-of-the-Art of the Problem)
https://doi.org/10.15360/1813-9779-2010-1-79
Abstract
By analyzing the data available in the Russian and foreign literature and their many years’ experience, the authors review the state-of-the-art of the problem associated with ventilator-associated pneumonia in intensive care units. The etiology, epidemiology, and pathogenesis of ventilator-associated pneumonia, the possibilities and limitations of its prevention and diagnostic methods, successes and difficulties and treatment of this pathology are described in detail.
References
1. Rello J., Ollendorf D. A., Oster G. et al.
2. Niederman M. S., Craven D. E., Fein A. M. et al.Pneumonia in the critically ill hospitalised patient. Chest 1990; 97 (1): 170—181.
3. Pingleton S. K., Fagon J. Y., Leeper K. V.Patient selection for clinical investigation of ventilator-associated pneumonia. Criteria for evaluating diagnostic techniques. Chest. 1992; 102 (5 Suppl 1): 553S—556S.
4. Light R.B.Ventilator associated pneumonia: asking the right question. Thorax 1999; 54 (10): 863—86
5. Rello J, Ausina V., Ricart M. et al.Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 1993; 104 (4): 1230—123
6. Rello J., Quintana E., Ausina V. et al.Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients, Chest 1991; 100 (2): 439—444.
7. Heyland D. K., Cook D. J., Griffith L. et al.The atributable morbitidy and mortality of ventilator associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am. J. Respir. Crit. Care Med. 1999, 159 (4 Pt 1): 1249—1256.
8. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990 — May 1999, issue June 1999. An. J. Infect. Control 1999; 27: 520—532.
9. Fagon J. Y., Chastre J., Hance A. J. et al.Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Amer. J. Med. 1993; 94 (3): 281—288.
10. Яковлев С. В.Госпитальные пневмонии вопросы диагностики и антибактериальной терапии Consilium medicum 2000, 2, 400—404.
11. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 2005, 171 (4): 388—416.
12. Bagshaw S. M., Laupland K. B.Epidemiology of intensive care unit-acquired urinary tract infections. Curr. Opin. Infect. Dis. 2006; 19 (1): 67—71.
13. Гельфанд Б. Р., Гологорский В. А., Белоцерковский Б. З. и соавт.Нозо-комиальная пневмония, связанная с ИВЛ у хирургических больных. М.; 2000.
14. Белобородова Н. В.Бактериемия и сепсис. Пособие для врачей «Инфекция в стационаре». М.; 2008.
15. Grigoriu B., Jacobs F., Beuzen F. et al.Bronchoalveolar lavage cytologi-cal alveolar damage in patients with severe pneumonia. Crit. Care 2006; 10 (1): R2.
16. Chastre J., Fagon J. Y., Soler P. et al.Diagnosis of nosocomial bacterial pneumonia in intubated undergoing ventilation: comparison of the usefulness of bronchoalveolar lavage and protected specimen brush. Amer. J. Med. 1988; 85 (4): 499—506.
17. Russwurms S., Wiederhold W., Oberhoffer M. et al.Procalcitonin as a monocyte marker for early diagnosis in septic abortus (in German). Z. Geburtsh Neonatal. 1999; 14: 29—33.
18. Nijsten M. W., Olinga P., de Vries E. G. et al.Procalcitonin behaves as a fast responding acute phase proteinin vivoandin vitro.Crit. Сare Med. 2000; 28 (2): 458-461.
19. Christ-Crain M., Jaccard-Stolz D., Bingisser R. et al.Effect of procalci-tonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004; 363 (9409): 600—607
20. Lowy F. D., Carlisle P. S., Adams A., Feiner C.The incidence of nosoco-mial pneumonia following urgent endotracheal intubation. Infect. Control 1987; 8 (6): 245—248.
21. Martone W. J., Jarvis W. R., Culver U. H., Haley R. W.Incidence and nature of endemic and epidemic nosocomial infections. In: Bennett JV, Brachman PS, eds. Hospital infections, 3rd ed. Boston: Little, Brown and Co.; 1993. 577—596.
22. Fagon J. Y.- Chastre J.- Hance A. J. et al.Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Amer. J. Med. 1993; 94 (3): 281—288.
23. Leu H. S.- Kaiser D. L.- Mori M. et al.Hospital-acquired pneumonia: attributable mortality and morbidity. Amer J Epidemiol 1989; 129 (6): 1258—1267.
24. Kollef M. H.- Ward S.The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998; 113 (2): 412—420.
25. Edmondson E. B.- Reinarz J. A.- Pierce A. K.- Sanford J. P.Nebulization equipment: a potential source of infection in gram-negative pneumonia’s. Amer. J. Dis. Child 1966; 111 (4): 357—360.
26. Kollef M. H.Ventilator-associated pneumonia: the importance of initial empirical antibiotic selection. Infect. Med. 2000; 17 (4): 265—268, 278—283.
Review
For citations:
Yegorova I.N., Vlasenko A.V., Moroz V.V., Yakovlev V.N., Alekseyev V.G. Ventilator-Associated Pneumonia: Diagnosis, Prevention, Treatment (State-of-the-Art of the Problem). General Reanimatology. 2010;6(1):79. (In Russ.) https://doi.org/10.15360/1813-9779-2010-1-79
Views:
2421
Email this article 